Advisers voted to recommend a third dose of Pfizer's vaccine in people 65 and older and those at high risk of severe Covid-19

Vaccine advisers to the US Food and Drug Administration voted unanimously Friday to recommend emergency use authorization of a booster dose of Pfizer's vaccine six months after full vaccination in people 65 and older and those at high risk of severe Covid-19.

Click Here to read the entire article...